Berdel WE, Bausert WR, Fink U, et al: Anti-tumor action of alkyl-lysophospholipids (Review). Anticancer Res. 1981, 1: 345-352.
CAS
PubMed
Google Scholar
Kondapaka SB, Singh SS, Dasmahapatra GP, et al: Perifosine, a novel alkylphospholipid, inhibits protein kinase B activation. Mol Cancer Ther. 2003, 2: 1093-1103.
CAS
PubMed
Google Scholar
Ruiter GA, Zerp SF, Bartelink H, et al: Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase-Akt/PKB survival pathway. Anticancer Drugs. 2003, 14: 167-173. 10.1097/00001813-200302000-00011.
Article
CAS
PubMed
Google Scholar
Hideshima T, Catley L, Yasui H, et al: Perifosine, an oral bio-active novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells. Blood. 2006, 107: 4053-4062. 10.1182/blood-2005-08-3434.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ruiter GA, Zerp SF, Bartelink H, et al: Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis. Cancer Res. 1999, 59: 2457-2463.
CAS
PubMed
Google Scholar
Bailey HH, Mahoney MR, Ettinger DS, et al: Phase II study of daily oral perifosine in patients with advanced soft tissue sarcoma. Cancer. 2006, 107: 2462-2467. 10.1002/cncr.22308.
Article
CAS
PubMed
Google Scholar
Van Ummersen L, Binger K, Volkman J, et al: A phase I trial of perifosine (NSC 639966) on a loading dose/maintenance dose schedule in patients with advanced cancer. Clin Cancer Res. 2004, 10: 7450-7456. 10.1158/1078-0432.CCR-03-0406.
Article
CAS
PubMed
Google Scholar
Michaelis LC, Ratain MJ: Measuring response in a post-RECIST world: From black and white to shades of grey. Nat Rev Cancer. 2006, 6: 409-414. 10.1038/nrc1883.
Article
CAS
PubMed
Google Scholar
Shoemaker RH: The NCI60 human tumour cell line anticancer drug screen. Nat Rev Cancer. 2006, 6: 813-823. 10.1038/nrc1951.
Article
CAS
PubMed
Google Scholar
Zaharevitz DW, Holbeck SL, Bowerman C, et al: COMPARE: A web accessible tool for investigating mechanisms of cell growth inhibition. J Mol Graph Model. 2002, 20: 297-303. 10.1016/S1093-3263(01)00126-7.
Article
CAS
PubMed
Google Scholar
[http://dtp.nci.nih.gov]
Paull KD, Shoemaker RH, Hodes L, et al: Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm. J Natl Cancer Inst. 1989, 81: 1088-1092. 10.1093/jnci/81.14.1088.
Article
CAS
PubMed
Google Scholar
Garraway LA, Widlund HR, Rubin MA, et al: Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005, 436: 117-122. 10.1038/nature03664.
Article
CAS
PubMed
Google Scholar
Staunton JE, Slonim DK, Coller HA, et al: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci USA. 2001, 98: 10787-10792. 10.1073/pnas.191368598.
Article
PubMed Central
CAS
PubMed
Google Scholar
Walsh AC, Feulner JA, Reilly A: Evidence for functionally significant polymorphism of human glutamate cysteine ligase catalytic subunit: Association with glutathione levels and drug resistance in the National Cancer Institute tumor cell line panel. Toxicol Sci. 2001, 61: 218-223. 10.1093/toxsci/61.2.218.
Article
CAS
PubMed
Google Scholar
Moisan F, Longy M, Robert J, et al: Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines. Br J Cancer. 2006, 95: 906-913. 10.1038/sj.bjc.6603361.
Article
PubMed Central
CAS
PubMed
Google Scholar
[http://dtp.nci.nih.gov]
Fang X, Shao L, Zhang H: Web-based tools for mining the NCI databases for anticancer drug discovery. J Chem Inf Comput Sci. 2004, 44: 249-257. 10.1021/ci034209i.
Article
CAS
PubMed
Google Scholar
[http://dtp.nci.nih.gov/docs/compare/compare.html]
[http://dtp.nci.nih.gov/mtargets/download.html]
R Development Core Team: R: A language and environment for statistical computing. 2006, R Foundation for Statistical Computing, Vienna, Austria
Google Scholar
Benjamini Y, Hochberg Y: Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc [Ser B]. 1995, 57: 289-300.
Google Scholar
[http://dtp.nci.nih.gov/docs/cancer/searches/standard_agent.html]
Boyd MR: Status of the NCI preclinical antitumor drug discovery screen. Cancer: Principles and Practice of Oncology. Edited by: DeVita, VT, Jr, Hellman, S, Rosenberg, SA. 1989, Lippincott, Philadelphia, PA, 1-12. 3
Google Scholar
Draghici S, Khatri P, Bhavsar P, et al: Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res. 2003, 31: 3775-3781. 10.1093/nar/gkg624.
Article
PubMed Central
CAS
PubMed
Google Scholar
Draghici S, Khatri P, Martins RP, et al: Global functional profiling of gene expression. Genomics. 2003, 81: 98-104. 10.1016/S0888-7543(02)00021-6.
Article
CAS
PubMed
Google Scholar
Khatri P, Bhavsar P, Bawa G, et al: Onto-Tools: An ensemble of web-accessible, ontology-based tools for the functional design and interpretation of high-throughput gene expression experiments. Nucleic Acids Res. 2004, 32: W449-456. 10.1093/nar/gkh409.
Article
PubMed Central
CAS
PubMed
Google Scholar
Ashburner M, Ball CA, Blake JA, et al: Gene Ontology: Tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000, 25: 25-29. 10.1038/75556.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kanehisa M, Goto S: KEGG: Kyoto encyclopedia ofgenes and genomes. Nucleic Acids Res. 2000, 28: 27-30. 10.1093/nar/28.1.27.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kanehisa M, Goto S, Kawashima S, et al: The KEGG resource for deciphering the genome. Nucleic Acids Res. 2004, 32: D277-D280. 10.1093/nar/gkh063.
Article
PubMed Central
CAS
PubMed
Google Scholar
Nielsen TO, West RB, Linn SC, et al: Molecular characterisation of soft tissue tumours: A gene expression study. Lancet. 2002, 359: 1301-1307. 10.1016/S0140-6736(02)08270-3.
Article
CAS
PubMed
Google Scholar
Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA. 2001, 98: 5116-5121. 10.1073/pnas.091062498.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sobell HM: Actinomycin and DNA transcription. Proc Natl Acad Sci USA. 1985, 82: 5328-5331. 10.1073/pnas.82.16.5328.
Article
PubMed Central
CAS
PubMed
Google Scholar
Kreft SG, Nassal M: hRUL138, a novel human RNA-binding RING-H2 ubiquitin-protein ligase. J Cell Sci. 2003, 116: 605-616. 10.1242/jcs.00261.
Article
CAS
PubMed
Google Scholar
Pray TR, Parlati F, Huang J, et al: Cell cycle regulatory E3 ubiquitin ligases as anticancer targets. Drug Resist Updat. 2002, 5: 249-258. 10.1016/S1368-7646(02)00121-8.
Article
CAS
PubMed
Google Scholar
Sun Y: E3 ubiquitin ligases as cancer targets and biomarkers. Neoplasia. 2006, 8: 645-654. 10.1593/neo.06376.
Article
PubMed Central
CAS
PubMed
Google Scholar
Geroldi D, Aldeghi A, Emanuele E: Perifosine may be of therapeutic usefulness in morbid obese females via inhibition of the PI3K/Akt signaling pathway. Med Hypotheses. 2007, 68: 236-
Article
CAS
PubMed
Google Scholar
Elrod HA, Lin YD, Yue P, et al: The alkylphospholipid perifosine induces apoptosis of human lung cancer cells requiring inhibition of Akt and activation of the extrinsic apoptotic pathway. Mol Cancer Ther. 2007, 6: 2029-2038. 10.1158/1535-7163.MCT-07-0004.
Article
CAS
PubMed
Google Scholar
Gajate C, Mollinedo F: Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts. Blood. 2007, 109: 711-719. 10.1182/blood-2006-04-016824.
Article
CAS
PubMed
Google Scholar
Nyakern M, Cappellini A, Mantovani I, et al: Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways. Mol Cancer Ther. 2006, 5: 1559-1570. 10.1158/1535-7163.MCT-06-0076.
Article
CAS
PubMed
Google Scholar
Zhang W, Duan S, Kistner EO, et al: Evaluation of genetic variation contributing to differences in gene expression between populations. Am J Hum Genet. 2008, 82: 631-640. 10.1016/j.ajhg.2007.12.015.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zhang W, Ratain MJ, Dolan ME: The HapMap Resource is providing new insights into ourselves and its application to pharmacogenomics. Bioinform Biol Insights. 2008, 2: 15-23.
PubMed Central
CAS
PubMed
Google Scholar
Munshi NC, Hideshima T, Carrasco D, et al: Identification of genes modulated in multiple myeloma using genetically identical twin samples. Blood. 2004, 103: 1799-1806. 10.1182/blood-2003-02-0402.
Article
CAS
PubMed
Google Scholar
Richardson P, Lonial S, Jakubowiak A, et al: Multi-center phase II study of perifosine (KRX-0401) alone and in combination with dexamethasone (dex) for patients with relapsed or relapsed/refractory multiple myeloma (MM): Promising activity as combination therapy with manageable toxicity. ASH Annual Meeting Abstracts. 2007, 110: 1164-
Google Scholar
Skubitz KM, Skubitz AP: Characterization of sarcomas by means of gene expression. J Lab Clin Med. 2004, 144: 78-91. 10.1016/j.lab.2004.04.005.
Article
CAS
PubMed
Google Scholar
Scherf U, Ross DT, Waltham M, et al: A gene expression database for the molecular pharmacology of cancer. Nat Genet. 2000, 24: 236-244. 10.1038/73439.
Article
CAS
PubMed
Google Scholar
Ross DT, Scherf U, Eisen MB, et al: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000, 24: 227-235. 10.1038/73432.
Article
CAS
PubMed
Google Scholar